Location History:
- Boussy St Antoine, FR (1993)
- Boussy St. Antoine, FR (1993)
Company Filing History:
Years Active: 1993
Title: The Contributions of Inventor Mohammad D. Mossalayi
In the field of pharmaceuticals and immunology, inventor Mohammad D. Mossalayi has made significant contributions through his innovative research and developments. He is based in Boussy St Antoine, France, and has garnered recognition for his work, holding two patents to his name.
Latest Patents
One of his noteworthy patents is focused on the "Maturation of Hemopoietic Cells." This invention encompasses a pharmaceutical preparation that includes the 25K IgE-binding factor (25K IgE-bf) and interleukin-1 (IL-1). The primary use of this preparation is aimed at stimulating the maturation of prothymocytes, which is crucial for the treatment of T cell immunodeficiencies and prothymocyte leukemias. This patent illustrates his dedication to advancing medical treatments and enhancing patient care.
Career Highlights
Mohammad D. Mossalayi is an accomplished professional who currently works with Ciba-Geigy Corporation, a notable player in the pharmaceutical industry. His role within the company enables him to leverage his expertise and contribute to the development of innovative solutions in medicine. His dedication and passion for his work in the biomedical field are reflected in his successful patent applications.
Collaborations
Throughout his career, Mossalayi has collaborated with various professionals, including his coworker Patrice Debre. These collaborations not only enhance his research capabilities but also foster an environment that encourages innovation and shared knowledge, leading to advancements in their respective fields.
Conclusion
In conclusion, Mohammad D. Mossalayi stands out as an influential figure in the realm of pharmaceutical innovation. His groundbreaking patents and collaborative efforts reflect his commitment to improving health outcomes and advancing medical science. As he continues to work with Ciba-Geigy Corporation, his future innovations hold great promise for the treatment of complex immunological conditions.